Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Morning Coffee on Knight Capital Group (KCG): Joyce to the World: "All Hands on Deck!"
-
Canaccord Genuity Morning Coffee on SPDR Retail ETF (XRT): Shop 'til You Drop!
-
Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); A Little Reaction or Side Effect?
-
Canaccord Genuity Maintains a 'Buy' on Synageva BioPharma (GEVA); SBC-102 P1/2 Extension Data Next
-
UPDATE: Correction - Canaccord Genuity Maintains a 'Buy' on Incyte (INCY); Q2 and Guidance Raises Several Questions
-
Canaccord Genuity Reiterates a 'Hold' on Momenta Pharmaceuticals (MNTA); Q2: First Clarity on Baxter (BAX) Biosimilars Deal
-
Canaccord Genuity on AVEO Pharmaceuticals (AVEO): FDA Concern on OS Rrend May Delay TIVO Filing
-
Canaccord Genuity Maintains a 'Hold' on Volcano Corp. (VOLC); Staying on Sidelines
-
Canaccord Genuity Maintains a 'Buy' on Obagi Medical Products (OMPI); Resurgence From Texas To Take Longer
-
Canaccord Genuity on AtriCure Inc. (ATRC): Bottom Line - Buy on Weakness
-
Canaccord Genuity Raising PT and Estimates on ResMed (RMD); Solid Q4
-
Canaccord Genuity Maintains a 'Hold' on Rubicon Technology (RBCN); Q2 Beat, But Waiting on Adoption
-
Canaccord Genuity Maintains a 'Buy' on Xylem (XYL); Adjusting Estimates Again
-
Canaccord Genuity Maintains a 'Hold' on MaxLinear (MXL); Story Intact Despite Revision
-
Canaccord Genuity Maintains a 'Buy' on DIRECTV (DTV); Bear Food
-
Canaccord Genuity Maintains a 'Buy' on SBA Communications (SBAC); Q1 Review: Yet Another Solid Qtr
-
Canaccord Genuity Maintains a 'Buy' on LinkedIn (LNKD); Strong Q2 and Increased Outlook
-
Canaccord Genuity Maintains a 'Buy' on Glu Mobile (GLUU); Slight Dip Before Pipeline Kicks In
-
Canaccord Genuity Reiterates a 'Buy' on SciQuest (SQI); Expect Acceleration in 2013
-
Canaccord Genuity Reiterates a 'Buy' on ON Semi (ONNN); Conservative Guidance
-
Canaccord Genuity Maintains a 'Buy' on Sierra Wireless (SWIR); Raising Numbers on Strong Q2
-
Canaccord Genuity Morning Coffee on Energizer Holdings (ENR): Need to Recharge?
-
Canaccord Genuity Morning Coffee on Avon Products (AVP): In Desperate Need of a Makeover
-
Canaccord Genuity Morning Coffee on Jeremy Grantham: Well, it's Groundhog Day...Again
-
Canaccord Genuity Morning Coffee on SPDR Homebuilders ETF (XHB): I Thought the House Always Wins?
-
Canaccord Genuity Maintains a 'Buy' on NPS Pharmaceuticals (NPSP); On the Shoulders of Gattex
-
Canaccord Genuity on BioMarin (BMRN): November Data + M&A Speculation = Top Pick
-
Canaccord Genuity Maintains a 'Hold' on Thoratec (THOR); Hammering Down Q2 Results; Prefer HTWR
-
Canaccord Genuity Reiterates a 'Buy' on STAAR Surgical (STAA); 2H Looks Bright
-
Canaccord Genuity Q1 Review on MAKO Surgical (MAKO): Shark Week Back in Focus
-
Canaccord Genuity Q2 Review on Itron (ITRI); Resilience Showing Rewards
-
Canaccord Genuity on First Solar (FSLR); Executing Better Than The Group, But...
-
Canaccord Genuity Maintains a 'Buy' on Jamba (JMBA); Model Going Profitable - Oh Yeah! Chica, Chica, Chic-aaa
-
Canaccord Genuity Maintains a 'Buy' on Time Warner (TWX), but Prefers NWSA, LMCA
-
Canaccord Genuity Raises Estimates and PT on American Tower (AMT); Strong Organic Core Growth in Q2
-
Canaccord Genuity on Carbonite (CARB): Need To See Bookings Accelerate To Keep 'Buy' Rating
-
Canaccord Genuity Cuts PT and Estimates on Smith Micro Software (SMSI); Q1 Loss as Rebuilding Continues
-
Canaccord Genuity Upgrades Cascade Microtech (CSCD) to Buy
-
After-Hours Movers 08/01: (FSLR) (CAVM) (GMCR) Higher; (HALO) (ANF) (WTW) Lower
-
Solta Medical (SLTM) Commences Common Offering
-
Streetinsider.com's Hot Lunchtime Reads 08/01: (TTWO) (JNJ) (YHOO) (CMI) (T) (KCG)
-
Canaccord Genuity Morning Coffee on UBS (UBS): Blame Game
-
Canaccord Genuity Morning Coffee on Seagate Technology (STX): Below Sea Level Results
-
Canaccord Genuity Morning Coffee on Coach (COH): Extreme Couponing: Luxury Edition
-
Canaccord Genuity Morning Coffee on BP (BP): Stands for "Bad Press"
-
Canaccord Genuity Morning Coffee on PIMCO’s Bill Gross Monthly Outlook: The Cult? Sea Shells Sanctuary?
-
Canaccord Genuity Reiterates a 'Buy' on Impax Laboratories (IPXL); Stock Can Run with 2H Catalysts
-
Canaccord Genuity on Optimer Pharmaceuticals (OPTR): June Blip, But Trends Remain Strong & Doctors Are Interested
-
Canaccord Genuity Reiterates a 'Buy' on Cytokinetics (CYTK); Keep Moving Forward
-
Canaccord Genuity Maintains a 'Buy' on ZELTIQ Aesthetics (ZLTQ); Strong Q2; Take Me To Your Leader

